Results 291 to 300 of about 97,116 (340)

Chemotherapy-induced cardiotoxicity in breast cancer: mechanisms, diagnostic advances, and emerging protective strategies. [PDF]

Am J Physiol Heart Circ Physiol
Ndzie Noah ML, Nath ND, Yoshioka J.
europepmc   +1 more source

Real‐World Outcomes of Polatuzumab Vedotin Plus R‐CHP Versus R‐CHOP‐Based Regimens in Japanese Patients With Untreated Diffuse Large B‐Cell Lymphoma

Cancer Medicine, Volume 15, Issue 1, January 2026.
PV‐R‐CHP showed improved progression‐free and overall survivals compared to R‐CHOP‐based regimens in newly diagnosed Japanese patients with DLBCL, particularly in those with non‐GCB subtype. These results were consistent in both the overall cohort and propensity score‐matched cohorts.
Masaaki Hotta, Atsushi Satake, Ayako Iwama, Tokiko Hoshiyama, Yukie Tsubokura, Hideaki Yoshimura, Shinya Fujita, Yumiko Kono, Tomoki Ito   +8 more
wiley   +1 more source

BMP-7 Treatment Ameliorates PTEN-Akt Mediated Apoptosis and Adverse Cardiac Remodeling in Ponatinib-Induced Cardiotoxicity. [PDF]

Pharmaceuticals (Basel)
Rolando JM, Singla DK.
europepmc   +1 more source

Antiurolithiatic Potential of a Series of Phthalimide Derivatives on Calcium Oxalate Crystals

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT Urolithiasis, primarily caused by calcium oxalate crystals, represents a major health concern due to high recurrence rates and limitations of current treatments in dissolving existing stones. This study investigated the antiurolithiatic potential of 15 phthalimide derivatives against calcium oxalate monohydrate (COM) and dihydrate (COD ...
Daniele Regina Sonza, Laura Von Borell du Vernay França, Rita de Cássia Vilhena da Silva, Anelize Dada, Mariana Zanovello, Thaise Boeing, Priscila de Souza, Rogério Correa   +7 more
wiley   +1 more source

Angiotensin converting enzyme inhibitors (ACEIs) for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Saudi Med
Safwan M, Bourgleh MS, AlShakaki H, Haider KH.   +3 more
europepmc   +1 more source

Targeting the TRIM28–EZH2 Protein–Protein Interface With Cysteine‐Reactive Covalent Inhibitors: A Computational Blueprint for Cancer Therapy

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
Graphical overview of the computational strategy employed to disrupt the oncogenic TRIM28EZH2 proteinprotein interaction. The workflow illustrates proteinprotein docking to define the interaction interface, cysteine‐focused covalent virtual screening targeting EZH2 Cys144, covalent docking, molecular dynamics simulations, and MM‐GBSA binding free ...
Ibrahim Oluwatobi Kehinde, Vuyisa Mzozoyana, Sizwe J. Zamisa, Mbuso Faya, Mahmoud E. S. Soliman   +4 more
wiley   +1 more source

Risk of cardiovascular disease and death in patients with breast cancer receiving anthracycline-based therapy: A retrospective cohort study. [PDF]

PLoS One
Lim YC, Lee YJ, Ha IH, Lee YS.
europepmc   +1 more source

Comment on "Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q₁₀ on Doxorubicin Pharmacokinetics During Breast Cancer Treatment". [PDF]

Integr Cancer Ther
Lei Z.
europepmc   +1 more source

Right ventricular vulnerability: a case study on anthracycline-induced cardiotoxicity post-pulmonary embolism recovery. [PDF]

Cardiooncology
Blair CA, Levitan BM, Brown T, Dewaswala N, Arbune A.   +4 more
europepmc   +1 more source